Related Experiment Video
Updated: Mar 1, 2026

12:10
Retzius-Sparing Robot-Assisted Radical Prostatectomy
Published on: May 19, 2022
9.6K
Comprehensive Geriatric Assessment in Men Aged 70 Years or Older with Localised Prostate Cancer Undergoing Radical
G E C Osborne1, S A Appleyard1, D C Gilbert1
1Sussex Cancer Centre, Brighton and Sussex University Hospitals NHS Trust, Brighton, UK.
Summary
Many older men with prostate cancer are vulnerable, but screening tools like VES-13 and G8 were not sensitive enough. Comprehensive geriatric assessment (CGA) did not predict radiotherapy toxicity in this age group.
Area of Science:
- Geriatric oncology
- Prostate cancer management
- Radiotherapy toxicity
Background:
- Treatment decisions for older men (70+) with localized prostate cancer require considering competing risks and treatment fitness.
- Comprehensive geriatric assessment (CGA) can aid in objective decision-making for this population.
Purpose of the Study:
- To describe CGA scores in older men with prostate cancer.
- To evaluate screening tools (VES-13, G8) for identifying health needs.
- To determine if CGA components predict acute radiotherapy toxicity.
Main Methods:
- Prospective cohort study of 178 men aged 70+ with localized prostate cancer undergoing radical external beam radiotherapy.
- Pretreatment comprehensive geriatric assessment (CGA), Vulnerable Elders Survey (VES-13), and G8 assessment were performed.
Main Results:
- 30.1% of participants had health needs identified by CGA.
- VES-13 and G8 showed significant association with CGA needs but had disappointing sensitivity.
- No association was found between CGA (or its components) and significant acute radiotherapy toxicity.
Conclusions:
- A significant proportion of older men with localized prostate cancer are vulnerable, as identified by CGA.
- Current screening tools (VES-13, G8) lack sufficient sensitivity for this population.
- CGA outcomes do not predict significant acute radiotherapy toxicity.
Keywords:
Comprehensive geriatric assessmentgeriatric oncologyprostate cancerradiotherapy tolerancescreening teststoxicity
